Edwards Lifesciences Corp·4

Sep 15, 5:01 PM ET

Markowitz Wayne 4

4 · Edwards Lifesciences Corp · Filed Sep 15, 2023

Insider Transaction Report

Form 4
Period: 2023-09-14
Markowitz Wayne
GM & SVP, Surgical
Transactions
  • Award

    Common Stock

    2023-09-14+7,2627,262 total
  • Award

    Employee Stock Option (Right to Acquire)

    2023-09-14+19,25619,256 total
    Exercise: $74.02From: 2024-09-14Exp: 2030-09-13Common Stock (19,256 underlying)
Footnotes (2)
  • [F1]These restricted stock units were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested annually in equal installments over a period of four years commencing one year after the grant date.
  • [F2]These options were granted on September 14, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable annually in equal installments over a period of four years commencing one year after the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary